These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 33636389)

  • 1. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia.
    Coarelli G; Darios F; Petit E; Dorgham K; Adanyeguh I; Petit E; Brice A; Mochel F; Durr A
    Neurobiol Dis; 2021 Jun; 153():105311. PubMed ID: 33636389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Changes of Clinical, Imaging, and Fluid Biomarkers in Preataxic and Early Ataxic Spinocerebellar Ataxia Type 2 and 7 Carriers.
    Coarelli G; Dubec-Fleury C; Petit E; Sayah S; Fischer C; Nassisi M; Gatignol P; Dorgham K; Daghsen L; Daye P; Cunha P; Kacher R; Hilab R; Hurmic H; Lamazière A; Lamy JC; Welter ML; Chupin M; Mangin JF; Lane R; Gaymard B; Pouget P; Audo I; Brice A; Tezenas du Montcel S; Durr A
    Neurology; 2024 Sep; 103(5):e209749. PubMed ID: 39133883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study.
    Wilke C; Bender F; Hayer SN; Brockmann K; Schöls L; Kuhle J; Synofzik M
    J Neurol; 2018 Jul; 265(7):1618-1624. PubMed ID: 29737427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.
    Wilke C; Mengel D; Schöls L; Hengel H; Rakowicz M; Klockgether T; Durr A; Filla A; Melegh B; Schüle R; Reetz K; Jacobi H; Synofzik M
    Neurology; 2022 May; 98(20):e1985-e1996. PubMed ID: 35264424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
    Byrne LM; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RAC; Scahill RI; Tabrizi SJ; Zetterberg H; Langbehn D; Wild EJ
    Lancet Neurol; 2017 Aug; 16(8):601-609. PubMed ID: 28601473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Clinical and Blood Biomarkers in Patients With Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3.
    Tezenas du Montcel S; Petit E; Olubajo T; Faber J; Lallemant-Dudek P; Bushara K; Perlman S; Subramony SH; Morgan D; Jackman B; Figueroa KP; Pulst SM; Fauret-Amsellem AL; Dufke C; Paulson HL; Öz G; Klockgether T; Durr A; Ashizawa T;
    Neurology; 2023 Apr; 100(17):e1836-e1848. PubMed ID: 36797067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic assessment of plasma biomarkers in spinocerebellar ataxia.
    Shen XN; Wu KM; Huang YY; Guo Y; Huang SY; Zhang YR; Chen SF; Wang HF; Zhang W; Cheng W; Cui M; Dong Q; Yu JT
    Neurobiol Dis; 2023 Jun; 181():106112. PubMed ID: 37003406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neurofilament light chain as a severity marker for spinocerebellar ataxia.
    Shin HR; Moon J; Lee WJ; Lee HS; Kim EY; Shin S; Lee ST; Jung KH; Park KI; Jung KY; Lee SK; Chu K
    Sci Rep; 2021 Jun; 11(1):13517. PubMed ID: 34188109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
    Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
    Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinocerebellar ataxia in a cohort of patients from Rio de Janeiro.
    Alvarenga MP; Siciliani LC; Carvalho RS; Ganimi MC; Penna PS
    Neurol Sci; 2022 Aug; 43(8):4997-5005. PubMed ID: 35469073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis and hierarchical clustering of infratentorial morphological MRI identifies SCAs phenogroups.
    Zhao J; Zeng W; Huang X; Hu M; Yuan K; Wu C; Qiu H; Chu J
    J Neurol; 2023 Sep; 270(9):4466-4477. PubMed ID: 37291395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
    Adanyeguh IM; Perlbarg V; Henry PG; Rinaldi D; Petit E; Valabregue R; Brice A; Durr A; Mochel F
    Neuroimage Clin; 2018; 19():858-867. PubMed ID: 29922574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy.
    Lirng JF; Wang PS; Chen HC; Soong BW; Guo WY; Wu HM; Chang CY
    PLoS One; 2012; 7(10):e47925. PubMed ID: 23118909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.
    Garcia-Moreno H; Prudencio M; Thomas-Black G; Solanky N; Jansen-West KR; Hanna Al-Shaikh R; Heslegrave A; Zetterberg H; Santana MM; Pereira de Almeida L; Vasconcelos-Ferreira A; Januário C; Infante J; Faber J; Klockgether T; Reetz K; Raposo M; Ferreira AF; Lima M; Schöls L; Synofzik M; Hübener-Schmid J; Puschmann A; Gorcenco S; Wszolek ZK; Petrucelli L; Giunti P
    Eur J Neurol; 2022 Aug; 29(8):2439-2452. PubMed ID: 35478426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The wide spectrum of spinocerebellar ataxias (SCAs).
    Manto MU
    Cerebellum; 2005; 4(1):2-6. PubMed ID: 15895552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias.
    Gan SR; Wang J; Figueroa KP; Pulst SM; Tomishon D; Lee D; Perlman S; Wilmot G; Gomez CM; Schmahmann J; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():492. PubMed ID: 29057148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.